Catalent Pharma Solutions plans to expand its biologics capabilities by relocating to a new, larger facility in Madison, WI, providing increased capacity for cell line and biomanufacturing solutions.   The new facility will quadruple capacity in Madison, allowing the company to enhance its offerings in the development and manufacturing of biologic products. The expansion will enhance Catalent’s GPEx cell line engineering technology and process development capabilities, as well as other mammalian...